PRA Health Sciences (PRAH) PT Raised to $108 at Mizuho Securities
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- S&P 500 ends down; Apple dips ahead of quarterly report
- Apple beats quarterly estimates for profit and revenue
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops 7% as Iran signals openness to peace talks
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
- After-Hours Movers: AMZN, TWLO, INTC, SNDK, RDDT, RBLX, PINS, RIVN, SBUX, ILMN
- After-Hours Movers: GOOGL, MSFT, NOW, KLAC. CMG, CVNA, TDOC
- After-Hours Movers: STX, ENPH, HOOD, V, CSGP, BOOM, CAKE, PPG, OI, TER
- After-Hours Movers: CLS, AVGO, CDNS, AMKR, WHR
- After-Hours Movers: WDC, BE, DECK, FIX, RNG
PRA Health Sciences, Inc. Reports Second Quarter 2020 Results and Provides Third Quarter and Full Year 2020 Guidance
August 6, 2020 4:02 PM EDTNet new business of $701.6 million; Net book-to-bill of 1.35 excluding reimbursement revenue
Net new business of $1,083.3 million; Net book-to-bill of 1.62 including reimbursement revenue$729.9 million of total revenue; representing a decrease of 4.4% at actual foreign exchange rates and 3.8% on a constant currency basisGAAP net income per diluted share of $0.22; GAAP net income of $13.9 million Adjusted net income per diluted share was $0.86; Adjusted net income of $55.2 millionFull year 2020 revenue guidance between $3.07 billion and $3.13 billion, GAAP net income per diluted share between $2.40 and $2.60 and adjusted net... More



